Investor profile
A-Level Capital
Micro-fund
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
A-Level Capital is a student-run venture capital firm founded in 2015 at Johns Hopkins University. Its thesis is hyper-focused on the Hopkins entrepreneurial ecosystem: the firm invests exclusively in early-stage startups founded or led by Johns Hopkins alumni and affiliates, believing that the JHU ecosystem has traditionally been underfunded. As stated on its website, 'We invest in a wide range of industries, but what unifies our investment thesis is that all the companies are Hopkins-affiliated. Our goal is to create a thriving entrepreneurial ecosystem at Hopkins that benefits both students and startups.' Beyond capital, A-Level provides portfolio companies with access to JHU student talent for internships, introductions to its LP and advisor network for follow-on fundraising, and the broader Hopkins professional network.
Notable quotes
“We invest in a wide range of industries, but what unifies our investment thesis is that all the companies are Hopkins-affiliated. Our goal is to create a thriving entrepreneurial ecosystem at Hopkins that benefits both students and startups.”
“As students, we bring something unique to the table: deep ties to the Hopkins campus and community. We're leveraging our network and connecting portfolio companies with incredible JHU talent, interns, and potential full-time hires.”
“A lot of students are not necessarily knowledgeable about how to raise funding and what resources are available in the ecosystem.”
Team
Brock Manz
Managing Partner
Nadia Momtaz
Managing Partner
Pratibha Pradeep
Managing Partner
Rose Majeed
Managing Partner
Elizabeth Galbut
Founding Partner
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Cerbrec | Seed | — | 2025-02-04 |
| Ashvattha Therapeutics | Undisclosed | — | 2025-01-13 |
| Dash (Healthcare Discovery Tools) | Undisclosed | — | 2024-10-08 |
| Sightline Climate | Undisclosed | — | 2024-08-28 |
| Glyphic Biotechnologies | Undisclosed | — | 2024-02-23 |
| Elemy | Seed | — | — |
| Insilico Medicine | Seed | — | — |
| Arkifi | Seed | — | 2023-07-01 |
| Leap AI | Seed | — | 2023-10-01 |
| Sherlock Biosciences | Seed | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Gaingels | 3 |
| 10X Capital | 1 |
| Singularity Capital | 1 |
| General Catalyst | 1 |
| Valor Equity Partners | 1 |
Fit check
Is A-Level Capital a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit